Mark Mobius, who put emerging markets on investors’ radar with on-the-ground insights over more than four peripatetic decades, has died. He was 89. FILE PHOTO: Mark Mobius, executive chairman at ...

Did our AI summary help? Mark Mobius, the veteran investor credited with bringing emerging markets into the global investment spotlight through decades of on-the-ground insights, has died at the age ...

Mark Mobius, who was known as the father of emerging markets and was among the first fund managers to invest in Hong Kong and mainland China, died on Wednesday at the age of 89, according to a ...

Mark Mobius, the investment guru who championed international markets from Brazil to Vietnam, has died, according to a statement from his LinkedIn page. He was 89. Mobius joined the money manager ...

Veteran emerging markets investor, Mark Mobius, has died aged 89. Mobius spent 30 years at Franklin Templeton where he ran one of the first emerging markets funds. He was executive chairman of the ...

Satellite imaging firm Planet Labs said on Saturday it will indefinitely withhold imagery of Iran and the conflict region in the Middle East to comply with a request from the U.S. government.

Mark Mobius, the veteran emerging markets investing pioneer, died at 89. Often referred to as the “Godfather of Emerging Markets,” Mobius visited 112 countries, wrote 15 books, once managed $40 ...

Satellite imaging company Planet Labs has said it will indefinitely withhold visuals of Iran and the ⁠region of conflict in the Middle East to comply with a request from United States President Donald ...

Veteran investor and a pioneer of emerging-market investments, Mark Mobius, passed away on 15 April 2026 at the age of 89 in Singapore. Mobius, often called the “Indiana Jones of emerging markets” for ...

At least once a year, you should be going to the doctor and undergoing a fair amount of lab work to make sure you're as healthy as you can be. Your doctor will likely gather a variety of metrics, ...

Experts warn consumers of unknown risks as one lab says about a third of samples fail basic quality checks What are peptides, are they safe and is there evidence to back up the hype? Is a new ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.